Planning robotic radiosurgery treatments for multiple (n > 3) metastatic brain lesions is challenging due to the need of satisfying a large number of dose-volume constraints and the requirement of prescribing different dose levels to individual targets. In this study, we developed a sequential two-step optimization technique to improve the planning quality of such treatments. In contrast to the conventional approach of where all targets are simultaneously planned, we have developed a two-step optimization method. In this method, the first step was to create treatment plans for individual targets. In the second step, the 3D dose matrices associated with each plan were exported to Dicom-RT digital files and subsequently optimized. For the optimization, a singular-value-decomposition (SVD) algorithm was implemented to minimize the dose interferences among different targets. Finally, we compared the optimized treatment plans with the treatment plans created using the conventional method to determine the effectiveness of the new method. Large improvements in target dose distributions as well as normal brain sparing were found for the two-step optimization treatment plans as compared with the conventional treatment plans. The two-step optimization significantly lowered the volume of normal brain receiving relatively low doses. For example, the normal brain volume receiving 12-Gy was reduced by averaged 42% (range 34%-47%) with the two-step optimization. Such improvements generally enlarged with increasing number of targets being treated regardless of target sizes. Of note, normal brain dose was found to increase non-linearly with increasing number of targets. In summary, a two-step optimization technique is demonstrated to significantly improve the treatment plan quality as well as reduce the planning effort for multi-target robotic radiosurgery.
Introduction
Stereotactic radiosurgery (SRS) plays an important role in managing multiple brain metastases (1-5). Multiple clinical studies have shown that SRS used as either definitive or salvage treatments can be effective in locally controlling metastatic brain lesions and improving patient survival. At our institutions, SRS is routinely being used for treatments of patients possessing multiple brain metastasis (n > 3) (5, 6) . A previous study (6) has shown that SRS alone can be as effective as other conventional radiotherapy treatments (whole-brain radiotherapy with or without SRS) for managing brain metastases regardless of the number of targets such as n > 6.
Since the advent of robotic radiosurgery, more and more patients with brain metastasis are being treated with this modality (7, 8) . However current studies are mainly focused on solitary lesions. In managing multiple metastatic lesions, one of the appealing features of robotic radiosurgery is its frameless setup and near real-time patient position tracking. Compared with other linear accelerator-based SRS systems, robotic radiosurgery is highly flexible in manipulating its non-isocentric beams with a full six degrees-of-freedom (9). In theory, this can be advantageous for multi-lesion treatments without a fixed isocenter, as any isocentric shifts of a conventional linear accelerator often requires manual adjustment of patient positions and verifications of each adjustment via redundant imaging procedures. Furthermore, recent implementation of high-output and short-path maneuvering capability (e.g., eliminating unnecessary pauses during beam positioning) of the robotic linear accelerator have also shortened the total treatment time in delivering a high fractional dose of radiation (7) . These advancements have made robotic radiosurgery a viable option for multi-target SRS. The goal of our study was to develop a new treatment planning approach to demonstrate the technical feasibility of multi-target SRS via non-isocentric robotic delivery and the potential benefits of such an approach.
However, it is technically challenging to plan a multi-target SRS treatment with robotic radiosurgery. This is due to the following reasons: (1) an increasing number of lesions significantly elevates the chance of entrance and exit beams crossing normal brain before reaching the target as well as the background (or scatter) dose to the normal brain tissues, which needs to be minimized as part of the treatment planning process, and (2) inter-lesion dose interference becomes complex (e.g., dose contribution from one lesion can significantly alter the dose to the other lesions) and the correction of such contributions to one lesion can non-uniformly affect the dose distribution to other lesions, etc. As a result, the number of permutations among different lesions and associated complexity increases rapidly with increasing number of the targets. Finally, the target locations and the target sizes can also vary significantly and clinical considerations often demand different dose prescribed with varied levels of conformity to individual lesions. This has made the current approach of prescribing a single dose to one selected isodose line, and then manually adjusting the planning parameters via a trial-and-error method a difficult and inefficient task. Even in a simple case of prescribing an identical dose to all the targets, different isodose levels still need to be selected for individual targets in order to achieve optimal dose coverage. This is similarly difficult to accomplish with the current treatment planning approach.
To overcome these challenges, we have developed a two-step sequential optimization approach with the aim of improving planning effort as well asplanning quality for multi-target robotic SRS treatments. In this paper, we will first describe the algorithm and the steps involved for the method. Then we demonstrate the implementation of the algorithm for a simulated patient treatment case. Finally, the two-step optimized treatment plans are compared with plans created using the conventional method.
Methods and Materials
An in-house program was developed for the study using Mathematica (Wolfram Research Inc., Champaign, IL). The sequential two-step optimization routine involves the following two steps: First, treatment plans for each target were created individually without considering the dose contributions from each other, i.e., one plan was created for each individual target. Accordingly, the dose was prescribed to cover each target as the user determined clinically. The 3D dose contributions of each plan was then saved into the Dicom RT format and exported into readable files by a program developed using Mathematica. Based on the exported 3D dose distributions, contributions from the selected target to other targets were extracted respectively. For example, from the treatment plan of the first target, the dose within the second, the third target contours etc. was extracted into separate matrices such as D 12 , D 13 , etc.
In the second step, the 3D dose matrices of all the target plans are summed together via a linear combination. The coefficients of such linear combination were determined via an optimization routine to account for inter-target interferences. These computed coefficients were then applied to individual treatment plans and summed together to produce the final optimal treatment plan.
In this step, the linear coefficients on the dose matrices D ij from each target were optimized via the following objective function,
where D ij is the dose contribution from the i th lesion to the j th lesion if i ≠ j, and if i 5 j, D ij is the dose prescribed for the i th lesion, D j is the optimization parameter associated with each lesion, and d ij is the Dirac delta function.
The above objective function can be analytically solved via the singular value decomposition (SVD) algorithm as follows,
where w k are the singular values of D ij from its LU decomposition denoted as V jk and U ki respectively. Since the dose fall-off is relatively sharp in robotic radiosurgery, the contributions from one lesion to its distal neighbors in D ij are generally small. Therefore, D ij typically forms a sparse matrix and the computation speed for the algorithm is high. As a result, the LU decomposition was commonly solved within a few seconds.
To test the functionality of the two-step optimization routine, we selected a patient case with 12 metastatic lesions. All lesions were contoured by a single attending radiation oncologist (Dr. David Larson), and the CT imaging studies for the case were exported via Dicom RT into the latest robotic radiosurgery (Cyberknife, Accuray Inc., Sunnyvale, CA) treatment planning system (Multiplan version 3.5) under a research-use license agreement. The target volumes for the lesions ranged from 0.036 to 1.10 cc. In addition to the target volumes, other critical structures such as the optic nerves, optic chiasm, lens and cochlea, etc. were also outlined. A 3D rendering of the target and patient images are given in Figure 1 .
For the study, we created subsets of possible target combinations for treatment planning with N 5 3, 6, 9, 12, respectively. For each target combination, 20 Gy in a single fraction was prescribed to cover at least 99% -100% of the target volumes. The normal structure constraints included the following: 1) the maximum dose to the optical structure such as optic nerves or optic chiasm was limited to 8 Gy, the maximum brainstem dose was limited to 10 Gy, the maximum lens dose was limited to be less than 2 Gy, and the maximum cochlea dose was to be less than 4 Gy (Tables I-II) .
For each target combination specified, we implemented the sequential two-step optimization procedure. The optimized treatment plan was compared with the conventional approach of planning-all-targets together. For the conventional approach, all targets are set with the dose prescriptions and normal organ constraints together so that the treatment step. To compare the plans, we calculated the target dose coverage, the target dose conformity, and the dose to the normal brains. The target dose coverage was defined as the percentage of target volume that falls within the prescription isodose line. The target dose conformity was defined as the ratio of the volume of the 100% prescription isodose line over the target volume and then such ratio normalized with the target dose coverage as defined above. On the clinical treatment planning system takes all constraints into account simultaneously via the sequential optimization routine in the clinical system (Multiplan 3.5, Accuray Inc. Sunnyvale). At the same time, the two-step optimized treatment plan was also compared with simple summation of individual target plans (i.e., the plan with no adjustment of inter-target dose contributions from the second step). This shows the extent of inter-target dose interference and the effects of the second optimization 
*Due to isodose overlap, one CI was computed for composite sum of these target volumes. and separated from each other. In the scenario that some of the targets are close to each other nearby targets can be then grouped together in a single region-of-interest while other targets can be optimized separately. The two-step optimization can then be performed using the optimization method described above. Figure 3 shows the isodose lines and the dose volume histogram (DVH) comparison for the two-step optimized plan and the conventional plan-all-lesions-together treatment plan. Note improvements in the dose conformity to the target near its periphery from the two-step optimized approach. From the DVH plot, dose fall-off improved significantly for all targets via optimization while still enforcing the clinical constraints that at least 99% of the target volume received a prescription dose of 20 Gy. Typically, the optimization parameters in the
Step 2 ranged from 0.76 to 0.91 suggesting individual plan adjustment of approximately 10-30% and these values tended to vary randomly from one target to another.
The summary of dose volume parameters for the target and normal structures for all the cases is listed in Tables I-II. From Table I , the target dose hot spots tend to be lower and the near-target dose conformity consistently improved for the two-step optimized treatment plans versus the conventional plan-all-lesions-together treatment plans. The MDPD in the table is defined as the maximum dose and the prescription dose ratio. For example, if 20 Gy is prescribed to the 80% isodose line, then MDPD equals to 1.25, i.e., inverse of 80%. From Table II , the critical structure constraints were satisfied for all the treatment plans. However, the peripheral normal planning system, the target dose conformity used for this study is denoted as nCI. Note that nCI is the same as the index previously reported by our institution (10), and is the inverse of the Paddick conformity index (11). We also report the ratio of the maximum dose to the prescription dose (MDPD).
To compare the conventional plan with the final optimized plan, individual plans were first normalized with the derived optimization parameters and then the individual plans of were summed together using the plan evaluation tool implemented in the clinical treatment planning system. For consistent comparison between the two treatment plans of the same combination of the targets, all dose computations were carried out using the high-resolution Monte Carlo algorithm implemented in the current treatment planning system.
Results
An illustration of the isodose distribution for a single-target treatment plan in step one is shown in Figures 1-2 . Figure 2 also lists the names given to all the the volumes of interest (VOI). These names are given based on the lesion locations. For example, 1RF means lesion number 1 located in the right frontal lobe, 2LF means lesion 2 located in the left frontal lobe etc. Note that the mean dose contribution from the lesion under consideration (1RF) to other lesions was zero except to the nearby second left frontal (2LF) and the No. 9 left occipital lesions (9LO), and reflects the sparsity of the dose matrix. The sparse nature of these dose matrices shows a commonly encountered scenario for planning a large number of intracranial metastases, i.e., these targets tend to be small in size via linear accelerators (13). When considering a large number of lesions, the key strength of the described technique is its simplicity in that its implementation is mostly insensitive to the increase in the total number of targets. This is in contrast to the conventional planning-all-lesions-together approach where the level of difficulty increases dramatically with increasing number of targets and correspondingly associated planning parameters and constraints. For example, if planning a single target involves satisfying 10 constraints with the use of 150 beams, then planning 10 targets together would require a planning system simultaneously satisfying 100 constraints involving 1500 beams simultaneously. Such high number of beams and constraints approached the system limit. Secondly, the technique by default groups and queues all the beams to irradiate one target at a time, in contrast to the conventional approach where all beams are lumped together. Beam grouping is advantageous as it facilitates treatment recovery and documentation in case of emergency or interruption during the treatment delivery.
The weakness of the approach is that the final plan quality is directly linked to the planning quality of multiple individual plans. This makes the final plan less adaptive to any changes brain dose as denoted by the 12-Gy volumes was found to be significantly lower for the optimized treatment plan as compared with either simple-summation of the individual plans or conventional treatment plans. Another comparison of peripheral dose to the normal brain is shown in Figure 4 , where the normal brain volumes enclosed by 16-Gy, 12-Gy, 8-Gy, 4-Gy isodose lines are plotted for different number of targets. From the results of Figure 4 , large decreases of as much as 40%, or 100 ml, in the normal brain volume being irradiated to these dose levels resulted. Furthermore, such decreases were found to scale approximately non-linearly with increasing number of targets regardless of target size and number of targets, as illustrated in the semi-logarithmic plot of Figure 4 . The trend of the data in Figure 4 generally followed the power relationship observed in our previous study (12) .
Discussion
Few studies have addressed the problems of planning multiple intracranial targets with linac-based SRS including robotic radiosurgery. In a previous study, we have reported on optimizing dose to a small number (N < 3) of lesions with the two-step optimization technique is likely a result of enlargement in the search space for handling a high number of beams and a large number of dose-volume constraints. Future studies will determine whether improvements in the current plan optimization process can further reduce these values. The results of this study provided the baseline value for such investigations.
Conclusion
We have described a two-step optimization approach for improving the multi-target treatment planning for robotic radiosurgery. The technique significantly improves the treatment planning quality particularly in the normal brain sparing for such treatments.
Figure 4:
Dependence of normal brain volumes receiving 16-Gy, 12-Gy, 8-Gy, and 4-Gy with increasing number of targets from 3 treatment planning approaches. On each line segment, the first data marker indicates the results of the conventional approach, the second indicates the results of simplesummation approach, and the third shows the result of the two-step optimization approach. Note consistent improvements in the normal brain sparing for the optimized approach regardless of the number of targets.
required. For example, if any global adjustments in the dose prescription or the critical structure dose volume constraints are needed, then all individual plans need to be adjusted and optimized first before the global adjustment can be achieved. Additionally, the final summed plan cannot be guaranteed to be a mathematical global optimum even though the plan for an individual target may be considered so on its own. This is because dose interplay effects among individual plans may not be linear as it was assumed for implementation of SVD algorithm in our method. This tends to be the case when fewer beams are involved to treat lesions closer together. In addition, given current machine output of 800 MU/min, each target is expected to take approximately 5-15 minutes for treatment and the overall treatment time would be approximately 2-3 hours for a 12-lesion delivery with our approach. This is consistently longer (~30-40%) than the conventional approach and is considered as a trade-off for gain in the treatment planning quality.
Finally, our study reported a non-linear dependence of the normal brain dose with increasing number of targets, which is of clinical significance and warrants further investigations. This is because normal brain isodose volumes such as the 10-Gy or 12-Gy isodose volume have been previously reported to correlate with the incidence of radionecrosis for radiosurgery (14, 15) . A non-linear dependency suggested that simple extrapolation of normal brain tolerance from N 5 1, or a small number of targets treatment, is likely invalid. The significant improvements in the 10-Gy or 12-Gy observed
